Cargando…
New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
Human Respiratory Syncytial Virus (hRSV) is one of the major causes of acute lower respiratory tract infections (ALRTI) worldwide, leading to significant levels of immunocompromisation as well as morbidity and mortality in infants. Its main target of infection is the ciliated epithelium of the lungs...
Autores principales: | Gálvez, Nicolás M. S., Soto, Jorge A., Kalergis, Alexis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578143/ https://www.ncbi.nlm.nih.gov/pubmed/28800119 http://dx.doi.org/10.3390/ijms18081753 |
Ejemplares similares
-
Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020) -
Modulation of host adaptive immunity by hRSV proteins
por: Espinoza, Janyra A, et al.
Publicado: (2014) -
TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
por: Rey-Jurado, Emma, et al.
Publicado: (2020) -
Lung pathology due to hRSV infection impairs blood–brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS
por: Bohmwald, Karen, et al.
Publicado: (2021) -
Human respiratory syncytial virus (hRSV) RNA quantification in nasopharyngeal secretions identifies the hRSV etiologic role in acute respiratory tract infections of hospitalized infants
por: Campanini, Giulia, et al.
Publicado: (2007)